TPC arrives at Thursday's Q1 2026 results on the back of a sharp re-rating — not a squeeze, not an analyst pivot, but a price surge that has left valuation multiples at their highest levels in over a year.
The stock has gained 25% over the past month and 13% in the past week alone, closing Wednesday at $96.98. That move has pushed the P/E to 18.5x and EV/EBITDA to 10.8x, with the latter rising more than 0.5x in a single session. The RSI14 now reads 75.9 — a level that typically signals an overbought condition — and the stock is up 38% year-to-date. Construction peers have also had a strong week: STRL exploded 70% on the week after its own earnings beat, and PRIM gained 20%, so sector tailwinds are clearly at work. But TPC's move is notable even within that context.
Options positioning offers little support for the idea that investors are anxious about the print. The put/call ratio is running at 0.46 — essentially dead in line with its 20-day average — and the z-score of -0.30 indicates no unusual hedging activity. Borrow conditions are equally relaxed. Short interest has drifted lower by 7% over the past month to 3.6% of the float, and the cost to borrow has fallen nearly 20% over the same period to just 0.35%. Availability is wide open relative to what is short. There is no meaningful pressure building in the lending market, and short sellers appear to be trimming rather than pressing.
The more interesting backdrop is on the insider side. In March, Executive Chairman Ronald Tutor sold over 152,000 shares at $67.76 — nearly $10.4 million — alongside the CEO and CFO, who collectively sold an additional $4.2 million worth of stock. Those sales came at levels roughly 30% below where TPC is trading today. Net shares over the 90-day window are positive due to simultaneous equity awards, but the open-market sales were unambiguously at the top of what was then the recent range. The stock has since blown through those sale prices. Analyst consensus, last updated in early March, carried a mean target of $109.50, which at that point implied meaningful upside. With the stock now at $97, the remaining gap to that target has compressed sharply — though the data is over 60 days stale and may not reflect current positioning.
The Q1 print will test whether the revenue and margin trajectory can justify a stock that has more than doubled its analyst price targets from 18 months ago, and whether the re-rating driven by peer-sector momentum has any fundamental underpinning behind it.
See the live data behind this article on ORTEX.
Open TPC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
